Product Description: O-Me Eribulin is a derivative of Eribulin and is an ADC cytotoxin that can be used for ADC synthesis. O-Me Eribulin can inhibit the cell viability of SKBR3, MDA-MB-468, and A549 cells, with IC50 values of 0.2052, 0.1827, and 0.5151 nM, respectively. O-Me Eribulin can be used for tumor research[1].
Applications: Cancer-programmed cell death
Formula: C41H61NO11
References: [1]Sun xing, et al. Drug conjugate of eribulin derivative. CN2022/107479. 2023-01-26.
CAS Number: 2676196-81-7
Molecular Weight: 743.92
Research Area: Cancer
Target: ADC Cytotoxin